Global Bacterial Vaccines Market Size By Type Of Vaccine (Capsular polysaccharide vaccines, Purified protein vaccines, Toxoid vaccines, Killed Bacterial Vaccines), By Route Of Administration (Oral, Intranasal, Injection), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Geographic Scope And Forecast

Bacterial Vaccines Market Size And Forecast

Bacterial Vaccine Market size was valued at USD 21.89 Billion in 2022 and is projected to reach USD 39.6 Billion by 2030, growing at a CAGR of 7.70% from 2024 to 2030.

The growth of the Bacterial Vaccines Market can be credited to Advancements in Industrialization and Urbanization, Increasing Environmental Awareness, growth in smart city initiatives, and technological progress. The Global Bacterial Vaccines Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market. The Global Bacterial Vaccines Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Bacterial Vaccines Market Definition

A Bacterial Vaccine is a suspension of killed or attenuated bacteria, which is administered inside the body to produce active immunity to the same organism. Antibodies are built against that particular bacteria, which helps to prevent bacterial infection later. Bacterial Vaccines can be produced in a variety of ways. A “whole-cell” vaccine (e.g., Bordetella pertussis) is produced by culturing and inactivating a pathogen strain. Bacterial Vaccines are composed of either whole bacteria (either killed or live, attenuated), bacterial capsular polysaccharides, toxoids, or purified proteins isolated from bacteria.

The vaccines against cholera, plague, typhus, and Q fever contain whole-killed bacteria. These vaccines are used only to protect those who are likely to be exposed. The live, attenuated Mycobacterium Bovis is used in the BCG vaccine to prevent tuberculosis. It is used in countries where the disease is frequently found. One of the vaccines against typhoid fever consists of live, attenuated S. Typhi. Vaccines consisting of capsular polysaccharides as the immunogen are directed against Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitides, and Salmonella typhi. To enhance the immune response, the capsular polysaccharide in the meningococcal, pneumococcal, and H. influenzae vaccines is conjugated to a carrier protein.

A toxoid is an inactivated toxin that has lost its ability to inflict disease but has retained its immunogenicity. (The pertussis vaccine also contains toxoid but along with other bacterial proteins as well). The vaccines against Diptheria and tetanus consist of toxoids as immunogens. Two vaccines contain purified bacterial proteins as the immunogen. The most commonly used is the acellular pertussis vaccine, which is in combination with diphtheria and tetanus. Toxoids are recommended for all children. Purified proteins are also contained in the vaccine against anthrax, however, it is recommended only for individuals who are likely to be exposed to the organism.

Global Bacterial Vaccines Market Overview

The primary driving factor for the growth of Global Bacterial Vaccines is the rising awareness about bacterial infections and the significance of getting vaccinated. Governments and health departments around the globe are making significant efforts to prevent infectious diseases. Availability of state-run vaccination programs where participation is boosted through awareness programs, and home vaccination services are some initiatives undertaken by governments and health departments that are helping to prevent infectious diseases such as bacterial diseases.

This is indirectly leading to the growth of the Global Bacterial Vaccines Market. Over the past few decades, Governments, as well as non-government organizations in emerging economies, have made massive efforts to raise awareness for preventive medicine. Programs that reach out to uneducated people especially in rural areas have been a key aim of such initiatives. This is a key factor boosting the Bacterial Vaccines Market in emerging economies of the world. Growing cases of various bacterial infections also drive the Bacterial Vaccines Market.

More than 2.8 million antibiotic-resistant illnesses occur in the U.S. each year, and as a result, more than 35,000 people pass away, according to the 2019 AR Threats report. However, lack of awareness regarding bacterial diseases in emerging economies, and probable side effects of the vaccination may hamper the Bacterial Vaccines Market. Increasing awareness of the vaccines and the ever-growing population presents a significant opportunity for growth for the Global Bacterial Vaccines Market.

Global Bacterial Vaccines Market Segmentation Analysis

The Global Bacterial Vaccines Market is Segmented on the Basis of Type of Vaccine, Route of Administration, Distribution Channel, and Geography.

Bacterial Vaccines Market, By Type of Vaccine

• Capsular polysaccharide vaccines
• Purified protein vaccines
• Toxoid vaccines
• Killed Bacterial Vaccines
• Live attenuated Bacterial Vaccines

Based on the Type of Vaccine, the market is segmented into Capsular polysaccharide vaccines, Purified protein vaccines, Toxoid vaccines, Killed Bacterial Vaccines, and Live attenuated Bacterial Vaccines. A major cause of worldwide diseases is encapsulated bacteria such as Streptococcus pneumonia, Neisseria meningitides, and Haemophilus influenza serogroup B (Hib). Vaccine development against these organisms has targeted their capsular polysaccharides (CPS), as anti-capsular antibodies often function to effectively protect against diseases.

Bacterial Vaccines Market, By Route of Administration

• Oral
• Intranasal
• Injection

Based on the Route of Administration, the market is segmented into Oral, Intranasal, and Injection. The oral route is administered by mouth, the intranasal route is administered into the nose and Bacterial Vaccines can also be administered by means of an Injection. The vaccine market is divided into parenteral and oral administration methods. Parenteral products will generate more income in 2022 due to the parenteral route’s maximum supply and sales around the globe. Due to the rising incidence of bacterial and viral diseases, this dominance is anticipated to continue throughout the projection period. Additionally, increased governmental organization procurement volume is projected to increase parenteral dose demand, leading to larger revenue generation in the ensuing years.

Bacterial Vaccines Market, By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Others

Based on the Distribution Channel, the market is bifurcated into Hospital Pharmacy, Retail Pharmacy, and Others. Hospital Pharmacy is expected to have a major market presence due to numerous hospitals providing such vaccinations. Given that vaccines are a shorter-duration operation frequently carried out at smaller institutions. Additionally, the growing preference for nearby vaccine access is probably what will drive this market’s development. Government agencies monitor hospitals and retail pharmacies all around the world to make sure that the demand is satisfied and that the shops have enough volume stock.

Bacterial Vaccines Market, By Geography

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

Based on Regional Analysis, the Global Bacterial Vaccine Market is classified into North America, Europe, Asia Pacific, Middle East Africa, and Latin America. North America is expected to be the region with the most amount of Business in the forecast period, owing to the well-established hospital infrastructure in these countries. Due to a variety of variables including vaccination awareness, the presence of strong manufacturers, and solid government policy surrounding health welfare, the market in North America is predicted to develop gradually and to hold the dominating market position. It also emphasizes the implementation of immunization throughout the nations of North America with appropriate financial policies.

Key Players

The “Global Bacterial Vaccines Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Serum Institute of India Pvt. Ltd., Emergent BioSolutions Inc., Pfizer Inc., Johnson & Johnson Services, Inc., Merck & Co. Inc., GlaxoSmithKline plc., Sanofi S.A., Astellas Pharma Inc., Emergent BioDefense Operations Lansing LLC, Wyeth Pharmaceuticals Inc., and Others.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the players mentioned above globally.

Key Developments

• July 2023, The World Health Organization (WHO) has prequalified MenFive®, the first conjugate vaccination to provide protection against the five most common forms of meningococcal meningitis in Africa. Serum Institute of India Pvt. Ltd. (SIIPL) and PATH worked together for 13 years to develop the program, and the UK government’s Foreign, Commonwealth and Development Office provided essential funding.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Bacterial Vaccines Market. We cover the major impacting factors driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the Global Bacterial Vaccines Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Report Scope

Top Trending Reports

Research Methodology of Market Research